Found 5 matching trials
Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
N/APHPC-02 is a phase II, randomized, placebo-controlled trial designed to inv...
Location
IRCCS Policlinico S. Matteo
Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
PHASE2DermaVir is a synthetic pathogen-like nanomedicine. The active pharmaceutic...
Location
ifi-Medizin GmbH at the Asklepios Klinik St. Georg
Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
PHASE1LC002 is an experimental therapeutic vaccine designed to boost the immune r...
Location
Univ. of California Davis Med. Ctr., ACTU
Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
PHASE1The therapeutic DNA vaccine, DermaVir, represents an immunization strategy ...
Location
Multiple Locations
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
PHASE1* DermaVir is a plasmid DNA-containing synthetic nanomedicine. It is admini...
Location
Saint Laszlo Hospital